GATEACRE BROW SURGERY
1 GATEACRE BROW, LIVERPOOL
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 100 | 127 | 78.7% | |
| CKD 4 | 2008 | 194 | 258 | 75.2% | |
| CKD 5 | 2009 | 41 | 51 | 80.4% | |
| CKD 5 | 2010 | 4 | 5 | 80.0% | |
| CKD 5 | 2011 | 4 | 5 | 80.0% | |
| CKD 5 | 2012 | 3 | 3 | 100.0% | |
| CKD 5 | 2013 | 4 | 5 | 80.0% | |
| CKD003 | 2014 | 5 | 6 | 83.3% | |
| CKD003 | 2015 | 4 | 4 | 100.0% | |
| NM84 | 2017 | 4 | 7 | 57.1% | |
| NM84 | 2018 | 4 | 7 | 57.1% | |
| NM84 | 2019 | 7 | 13 | 53.8% | |
| NM84 | 2020 | 6 | 12 | 50.0% | |
| NM84 | 2022 | 6 | 12 | 50.0% | |
| NM84 | 2023 | 5 | 10 | 50.0% |
